Abstract
Dynorphin A 1–17 (DYN A) is an endogenous neuropeptide that is of interest due to its diverse roles in analgesia, inflammation and addiction. Upon release, DYN A is subject to metabolism by a range of enzymes and its biotransformation is dependent on the site and environment into which it is released. In this study, we investigated the biotransformation of DYN A in rat inflamed tissue at pH 7.4 and 5.5, in rat serum and in trypsin solution. DYN A-porcine was incubated at 37 °C in each matrix over a range of incubation periods. The resultant fragments were separated using a C4 column and detected by mass spectrometry using total ion current mode. Incubation of DYN A in trypsin solution and in rat serum resulted in 6 and 14 fragments, respectively. Incubation in inflamed rat paw tissue occasioned 21 fragments at pH 7.4 and 31 fragments at pH 5.5. Secondary breakdown of some larger primary fragments was also observed in this study.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Day R, Lazure C, Basak A, Boudreault A, Limperis P, Dong W, Lindberg I (1998) J Biol Chem 273:829–836
Inan S, Cowan A (2006) Pharmacol Biochem Behav 85:39–43
Tiseo PJ, Geller EB, Adler MW (1988) J Pharmacol Exp Ther 246:449–453
Tsushima H, Mori M, Matsuda T (1993) Jpn J Pharmacol 63:461–468
Narita M, Kishimoto Y, Ise Y, Yajima Y, Misawa K, Suzuki T (2005) Neuropsychopharmacology 30:111–118
Chou JZ, Chait BT, Wang R, Kreek MJ (1996) Peptides 17:983–990
Klintenberg R, Andren PE (2005) J Mass Spectrom 40:261–270
Muller S, Hochhaus G (1995) Pharm Res 12:1165–1170
Reed B, Zhang Y, Chait BT, Kreek MJ (2003) J Neurochem 86:815–823
Ahmed MS, Cemerikic B, Agbas A (1992) Life Sci 50:83–97
Cabot PJ, Carter L, Schafer M, Stein C (2001) Pain 93:207–212
Sidhu P, Shojaee AF, Andrews M, Lees P (2003) Res Vet Sci 74:67–77
Weiss C, Kaplan A, Larson CE (1938) J Biol Chem 125:247–257
Nissen JB, Iversen L, Kragballe K (1995) Br J Dermatol 133:742–749
Berman Y, Ageyeva L, Veksler B, Wood D, Devi LA (1999) J Biochem 125:641–647
Auld DS, Vallee BL (1970) Biochemistry 9:4352–4359
Polgar L (1991) Eur J Biochem 197:441–447
Herath HM, Cabot PJ, Shaw PN, Hewavitharana AK (2012) Anal Bioanal Chem 402:2089–2100
Chavkin C, Goldstein A (1981) Proc Natl Acad Sci U S A 78:6543–6547
Svensson CI, Hua XY, Powell HC, Lai J, Porreca F, Yaksh TL (2005) Neuropeptides 39:485–494
Ichinose M, Asai M, Sawada M (1995) J Neuroimmunol 60:37–43
Wei ET, Thomas HA, Gjerde EA, Reed RK, Burov SV, Korolkov VI, Glynskaya OV, Dorosh MY, Vlasov GP (1998) Peptides 19:767–775
Blanchard J (1981) J Chromatogr 226:455–460
Karol MD (1990) Biopharm Drug Dispos 11:179–181
Goldstein A, Fischli W, Lowney LI, Hunkapiller M, Hood L (1981) Proc Natl Acad Sci U S A 78:7219–7223
Yu J, Butelman ER, Woods JH, Chait BT, Kreek MJ (1996) J Pharmacol Exp Ther 279:507–514
Benuck M, Berg MJ, Marks N (1984) Neurochem Res 9:733–749
Silberring J, Castello ME, Nyberg F (1992) J Biol Chem 267:21324–21328
Thomas HA, Wei ET (1995) Peptides 16:547–550
Acknowledgements
H. M. D. R. Herath was supported by Australian Agency for International Development (AusAID) leadership award.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Morgan, M., Herath, H.M.D.R., Cabot, P.J. et al. Dynorphin A 1–17 biotransformation in inflamed tissue, serum and trypsin solution analysed by liquid chromatography–tandem mass spectrometry. Anal Bioanal Chem 404, 3111–3121 (2012). https://doi.org/10.1007/s00216-012-6406-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-012-6406-8